Stocks and Investing Stocks and Investing
Mon, March 2, 2020
Fri, February 28, 2020
Thu, February 27, 2020
Wed, February 26, 2020

Matthew Harrison Maintained (BLUE) at Hold with Decreased Target to $92 on, Feb 26th, 2020


Published on 2024-10-26 22:40:52 - WOPRAI, Matthew Harrison
  Print publication without navigation


Matthew Harrison of Morgan Stanley, Maintained "bluebird bio, Inc." (BLUE) at Hold with Decreased Target from $100 to $92 on, Feb 26th, 2020.

Matthew has made no other calls on BLUE in the last 4 months.



There are 5 other peers that have a rating on BLUE. Out of the 5 peers that are also analyzing BLUE, 1 agrees with Matthew's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Benjamin Burnett of "Stifel" Maintained at Hold with Decreased Target to $94 on, Wednesday, February 19th, 2020


These are the ratings of the 4 analyists that currently disagree with Matthew


  • Joshua Schimmer of "Evercore ISI Group" Upgraded from Hold to Buy and Increased Target to $100 on, Monday, February 3rd, 2020
  • Mark Breidenbach of "Oppenheimer" Upgraded from Hold to Buy and Held Target at $135 on, Friday, December 13th, 2019
  • Yanan Zhu of "Wells Fargo" Maintained at Buy with Decreased Target to $160 on, Monday, December 9th, 2019
  • Mani Foroohar of "SVB Leerink" Upgraded from Hold to Buy and Held Target at $119 on, Tuesday, November 26th, 2019